Valeria Stati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Valeria Stati has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Gian Paolo Spinelli
UOC Oncologia Territoriale, ASL Latina, CDS Aprilia, La Sapienza Università Di Roma Polo Pontino, 04100 Latina, Italy
3 shared publications - Giuseppe Lo Russo
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
3 shared publications - Evelina Miele
Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
2 shared publications - Federica Tomao
Department of Maternal and Child Health and Urological Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
2 shared publications - Martina Strudel
Oncology Unit, Department of Medico-Surgical Sciences and Biotechnologies, University of Rome "Sapienza", Latina, Italy
2 shared publications - Natalie Prinzi
Medical Oncology, Foundation IRCCS National Cancer Institute, 20133 Milano, Italy
2 shared publications
Latest Publications
- Open Access
- 20 June 2013
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 7 (1) , 161
A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report
Introduction: Lymphoepithelioma is a very rare form of malignant tumor originating from epithelial line cells. Its occurrence has potential clinical, therapeutic and prognostic implications. In the present report we describe an unusual case of bladder cancer with two different histological varieties: transition cell carcinoma and lymphoepithelioma-like carcinoma. Lymphoepithelioma-like carcinoma of the bladder has only been rarely reported in the literature to date. Case presentation: We present the case of a 68-year-old Caucasian man who, after occurrence of hematuria, underwent transurethral resection of a bladder tumor. The results of a histological examination confirmed a high-grade non-muscle-invasive pT1 lymphoepithelioma-like carcinoma of the urinary bladder, associated with a concurrent high-grade transition cell carcinoma. After analyzing the histological features, our patient was subjected to treatment with intra-vesical instillations of bacillus Calmette-Guérin. Our work stresses that diagnosis and therapeutic approaches can be difficult and controversial, especially in the early stages of this rare carcinoma. Conclusions: This report emphasizes the importance of extending our knowledge and experiences regarding this uncommon carcinoma. Further studies are needed to better understand this rare disease and define more accurate diagnostic and therapeutic strategies.
- 20 June 2013
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 7 (1) , 161
Open AccessA 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report
Introduction: Lymphoepithelioma is a very rare form of malignant tumor originating from epithelial line cells. Its occurrence has potential clinical, therapeutic and prognostic implications. In the present report we describe an unusual case of bladder cancer with two different histological varieties: transition cell carcinoma and lymphoepithelioma-like carcinoma. Lymphoepithelioma-like carcinoma of the bladder has only been rarely reported in the literature to date. Case presentation: We present the case of a 68-year-old Caucasian man who, after occurrence of hematuria, underwent transurethral resection of a bladder tumor. The results of a histological examination confirmed a high-grade non-muscle-invasive pT1 lymphoepithelioma-like carcinoma of the urinary bladder, associated with a concurrent high-grade transition cell carcinoma. After analyzing the histological features, our patient was subjected to treatment with intra-vesical instillations of bacillus Calmette-Guérin. Our work stresses that diagnosis and therapeutic approaches can be difficult and controversial, especially in the early stages of this rare carcinoma. Conclusions: This report emphasizes the importance of extending our knowledge and experiences regarding this uncommon carcinoma. Further studies are needed to better understand this rare disease and define more accurate diagnostic and therapeutic strategies.
- Open Access
- 19 July 2012
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 6 (1) , 212
Subcutaneous metastases from colon cancer: a case report
Introduction: Dukes A stages of colorectal cancer are rarely reported to metastasize. Subcutaneous or skin metastases from colon cancer are rare events and usually indicate widespread disease. Case presentation: We present the case of a 72-year-old Caucasian woman with Dukes A colorectal cancer at diagnosis and, three years later, a single secondary subcutaneous involvement with no other metastatic sites. The description of this case is supported by critical analysis of its clinical, radiological and pathological features. Our report illustrates that diagnosis can be difficult and controversial when relapse occurs in early stage patients and at uncommon sites. Conclusion: The unusual and aggressive course of the reported disease stresses the importance of intensive follow-up in colorectal cancer patients with good prognostic factors.
- 19 July 2012
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 6 (1) , 212
Open AccessSubcutaneous metastases from colon cancer: a case report
Introduction: Dukes A stages of colorectal cancer are rarely reported to metastasize. Subcutaneous or skin metastases from colon cancer are rare events and usually indicate widespread disease. Case presentation: We present the case of a 72-year-old Caucasian woman with Dukes A colorectal cancer at diagnosis and, three years later, a single secondary subcutaneous involvement with no other metastatic sites. The description of this case is supported by critical analysis of its clinical, radiological and pathological features. Our report illustrates that diagnosis can be difficult and controversial when relapse occurs in early stage patients and at uncommon sites. Conclusion: The unusual and aggressive course of the reported disease stresses the importance of intensive follow-up in colorectal cancer patients with good prognostic factors.
- Open Access
- 9 July 2012
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 10 (1) , 137
Breast cancer metastatic to the pituitary gland: a case report
Metastases to the pituitary gland are rare events, and usually indicate widespread malignant disease. The lung and the breast are the most common sites of primary tumors that metastasize to the pituitary gland.
- 9 July 2012
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 10 (1) , 137
Open AccessBreast cancer metastatic to the pituitary gland: a case report
Metastases to the pituitary gland are rare events, and usually indicate widespread malignant disease. The lung and the breast are the most common sites of primary tumors that metastasize to the pituitary gland.